← Back to Clinical Trials
Recruiting NCT03120481

NCT03120481 Controls for Respiratory Diseases

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT03120481
Status Recruiting
Phase
Sponsor Seoul National University Hospital
Condition Chronic Obstructive Pulmonary Disease
Study Type OBSERVATIONAL
Enrollment 1,572 participants
Start Date 2017-04-10
Primary Completion 2037-02-28

Eligibility & Interventions

Sex All sexes
Min Age 19 Years
Max Age 90 Years
Study Type OBSERVATIONAL
Interventions
no intervation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,572 participants in total. It began in 2017-04-10 with a primary completion date of 2037-02-28.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This is the registry of control participants for patients with various respiratory diseases. We screened healthy volunteers who visited Seoul National Hospital Healthcare System Gangnam Center for routine health check-up, and enrolled patients who agree to participate in the study. The participants undergo baseline questionnaires, provide blood specimen and information of the results of health check-up. We will include participants as controls if they have no significant respiratory symptom and no significant radiographic abnormality. The data from this registry will be compared with those from other registry of various respiratory diseases

Eligibility Criteria

Inclusion Criteria: * 19-90 years old male and female * underwent health check-up including chest radiography * obtained informed consent Exclusion Criteria: * those who showed a significant abnormal finding of chest radiography * those who reported a significant respiratory symptoms

Contact & Investigator

Central Contact

Chang-Hoon Lee, M.D.

✉ kauri670@gmail.com

📞 82-2-2072-4743

Principal Investigator

Chang-Hoon Lee, M.D.

PRINCIPAL INVESTIGATOR

Seoul National University Hospital

Frequently Asked Questions

Who can join the NCT03120481 clinical trial?

This trial is open to participants of all sexes, aged 19 Years or older, up to 90 Years, studying Chronic Obstructive Pulmonary Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT03120481 currently recruiting?

Yes, NCT03120481 is actively recruiting participants. Contact the research team at kauri670@gmail.com for enrollment information.

Where is the NCT03120481 trial being conducted?

This trial is being conducted at Seoul, South Korea.

Who is sponsoring the NCT03120481 clinical trial?

NCT03120481 is sponsored by Seoul National University Hospital. The principal investigator is Chang-Hoon Lee, M.D. at Seoul National University Hospital. The trial plans to enroll 1,572 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology